CHLORHEXIDINE ACETATE WITH CETRIMIDE (%) ANTISEPTIC SOLUTION



Similar documents
Liquid antiseptic concentrate for external use. Bankside House Bankside Business Park Coronation Street South Reddish Stockport Cheshire SK5 7PG

used to treat inflammation, corneal injury and bacterial infections in the external part of the eye.

MATERIAL SAFETY DATA SHEET

3% Sodium Chloride Injection, USP 5% Sodium Chloride Injection, USP

MATERIAL SAFETY DATA SHEET

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP

1g cream or ointment contains 1 mg methylprednisolone aceponate.

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

MATERIAL SAFETY DATA SHEET

Safety Data Sheet Avesta Neutralization Agent 502

I B2.4. Design of the patient information leaflet for VariQuin

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection.

MATERIAL SAFETY DATA SHEET TOILET BOWL SANITIZER

ZOVIRAX Cold Sore Cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

MATERIAL SAFETY DATA SHEET

Clinical Performance Director of Nursing Allison Bussey

NEW ZEALAND DATA SHEET NAPHCON-A Naphazoline hydrochloride and pheniramine maleate.

Emergency Telephone (800)

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

Agricultural and Veterinary Chemicals Code (Listed Chemical Product Home Swimming Pool and Spa Products) Standard 2014

NQF Level: 2 US No:

Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006

SAFETY DATA SHEET. according to 1907/2006/EC, Article 31 CYTOFIXX (CYTOLOGICAL FIXATIVE)

Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home

EU SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 and Regulation (EU) No 453/2010 (REACH)

YOUR GUIDE TO THE LANTUS SOLOSTAR INSULIN PEN

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)

VISTARIL (hydroxyzine pamoate) Capsules and Oral Suspension

MATERIAL SAFETY DATA SHEET

UW School of Dentistry Comprehensive Medication Policy

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013.

MATERIAL SAFETY DATA SHEET SECTION 1. IDENTIFICATION OF SUBSTANCE AND CONTACT INFORMATION

Pesticide Harmful Effects And Emergency Response

1 What Anapen is and what it is used for?

Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

SUMMARY OF PRODUCT CHARACTERISTICS

White, circular, biconvex, uncoated tablets with a score line on one side, plain on the other.

Ingredient % content Hazard data Cross linked Sodium Polyacrylite CAS No: Non chemical fillers Zeolite 1-10

Food allergy /anaphylaxis

PHOSPHATE-SANDOZ Tablets (High dose phosphate supplement)

FLAMAZINE CREAM MSDS No. 185

Reference: HSHARP2IN1 Creation date: 27 November 2002 Page 1 of 7

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Creation Date: Revision Date: Page: 1 of 7

Material Safety Data Sheet

MATERIAL SAFETY DATA SHEET F10 GERMICIDAL TREATMENT SHAMPOO

SAFETY DATA SHEET Easy Aloe Vera Non-Bio Washing Powder

3M TM DuraPrep TM Surgical Solution (Iodine Povacrylex [0.7% available iodine] and Isopropyl Alcohol, 74% w/w) Patient Preoperative Skin Preparation

Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS

How to Prepare Powdered Infant Formula in Care Settings

SUMMARY OF PRODUCT CHARACTERISTICS. Albuman 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.

MATERIAL SAFETY DATA SHEETS

MATERIAL SAFETY DATA SHEET MULTI GUARD

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (HCl) STEROP 0,8mg/1ml. Solution for injection. Adrenaline (Levorenine, Epinephrine)

Data Sheet. Paraldehyde

0.9% Sodium Chloride Injection, USP In VIAFLEX Plastic Container

Food Safety Guide for Family Day Care Educators

Material Safety Data Sheet

ROFERON-A PFS 3 M IU/0.5 ml

Anaphylaxis. Exceptional healthcare, personally delivered

BLOOD BORNE PATHOGENS

Hazardous Drugs Spill Kit

SAFETY DATA SHEET. Blue Hand and Body Shampoo

Material Safety Data Sheet

Autofoam SAFETY DATA SHEET

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and Clotrimazole 1% w/w

COMPOSITION / INFORMATION ON INGREDIENTS

TdaP-Booster (tee-dee-ay-pee boo-ster)

MATERIAL SAFETY DATA SHEET

Naloxone Hydrochloride Injection PRODUCT INFORMATION

Material Safety Data Sheet

Revised: 1/1/2001 N/A MSDS. Material Safety Data Sheet

SAFETY DATA SHEET according to 1907/2006/EC, Article 31

MATERIAL SAFETY DATA SHEET

PACUC Guidelines. Rodent Survival Surgery

GESSO PRIMER WHITE DALER ROWNEY, 2 Corporate Drive, Cranbury, New Jersey, USA

MATERIAL SAFETY DATA SHEETS

EXPERIMENT # 3 ELECTROLYTES AND NON-ELECTROLYTES

1. Product and Company Identification

CCA TODDLER SUNSCREEN SPF30+ FUN GREEN CREAM Chemwatch Material Safety Data Sheet Issue Date: 21-Jul-2008 CHEMWATCH

Material Safety Data Sheet

SAFETY DATA SHEET KB 26/10. Revision date: 26/01/2011. Print date: 22/04/2013

: MR MUSCLE Window & Glass Cleaner

CONTROLLING CROSS INFECTION IN THE DENTAL LABORATORY. Best Practice Guide

RBS detergents for laboratories

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer )

Before performing a procedure, it is important to receive consent from the patient:

MATERIAL SAFETY DATA SHEET In accordance with CE Regulation n 1907/2006. Annex II.

PRODUCT INFORMATION PANAMAX

Product Code: VLB ml cartridges. Substance Name EC No. CAS No. % by Wt Hazard Symbols n Butylacetate

Cleaning. By the end of this chapter, you will be able to: Introduction. Definitions. Chapter 9

MATERIAL SAFETY DATA SHEET. 1. Product and Company Identification

SECTION 1 - PRODUCT IDENTIFICATION

Stalosan F Safety Data Sheet 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Package leaflet : information for the user. Dilute Adrenaline/Epinephrine Injection 1:10,000 adrenaline (epinephrine) (as acid tartrate) 0.

Hand Dermatitis in Health Care Workers

SUMMARY OF PRODUCT CHARACTERISTICS

T 465 Bucasan Pino Date of issue: Page 1 of 10

PRODUCT INFORMATION. SODIUM CHLORIDE (0.9%) INTRAVENOUS INFUSION in AVIVA Plastic Container

Transcription:

CHLORHEXIDINE ACETATE WITH CETRIMIDE (%) ANTISEPTIC SOLUTION NAME OF THE MEDICINE Proprietary name: Non-proprietary name: Chemical Name: Molecular formula: Baxter Chlorhexidine Cetrimide Antiseptic Solution Chlorhexidine Acetate with Cetrimide Irrigating Solution Chlorhexidine (CAS number: 55-56-1) and Acetate (CAS number: 56-95-1) is a 1,1- hexamethylenebis[4-(4- chlorophenyl)biguanide] diacetate, and Cetrimide (CAS number 505-86-2) is trimethyltetraecylammonium bromide C 22 H 3 OCl 2 N 10 2C 2 H 4 O 2 and C 17 H 38 BrN. DESCRIPTION Chlorhexidine Acetate (0.015%, 0.05% and 0.1%) with Cetrimide Antiseptic Solutions are yellow sterile solutions. Active Ingredients: Chlorhexidine Acetate BP 0.015% w/v, 0.05% w/v and 0.1% w/v and Cetrimide 0.15% w/v, 0.5% w/v and 1.0% w/v. Inactive Ingredients: Tartrazine Cl 19140, glacial acetic acid and water for injections BP. The solution is used for cleaning and disinfecting wounds and as an antiseptic treatment for burns. The solution is hypotonic and haemolytic. It is supplied in 3 strengths. Each strength is supplied in 3 sizes (see Table 1). PHARMACOLOGY Chlorhexidine Acetate with Cetrimide Antiseptic Solution is used as a topical solution; it must not be administered intravenously. Cetrimide is a quaternary ammonium antiseptic with actions and uses typical of cationic surfactants. These surfactants dissociate in aqueous solution into a relatively large and complex cation, which is responsible for the surface activity, and a smaller inactive anion. In addition to emulsifying and detergent properties, quaternary ammonium compounds have bactericidal activity against Gram-positive and, at the higher concentrations, against some Gram-negative bacteria. Some Pseudomonas spp. are particularly resistant as are strains of Mycobacterium tuberculosis. They are ineffective against bacterial spores, have variable antifungal activity, and are effective against some viruses. Quaternary ammonium compounds are most effective in neutral or slightly alkaline solutions and their bactericidal activity is appreciably reduced in acid media; alcohols enhance their activity. Page 1 of 5

INDICATIONS Chlorhexidine Acetate with Cetrimide Antiseptic Solution is used as a general antiseptic. It is used for the cleaning and disinfecting of wounds as an antiseptic treatment for burns. CONTRAINDICATIONS Known hypersensitivity to chlorhexidine or cetrimide. Chlorhexidine Acetate with Cetrimide Antiseptic Solution should not be used in the eye, intravenously, orally, in the auditory canal (especially perforated eardrums) or near meninges, brain or spinal cord. PRECAUTIONS Chlorhexidine Acetate with Cetrimide Antiseptic Solution should not be used intravenously or taken orally. This product should not be used in body cavities or as an enema. Chlorhexidine should not be used in preoperative skin preparations for the face and head. It should not be used for the disinfection of soft contact lenses. The use of chlorhexidine solutions, both alcohol based and aqueous, for skin antisepsis prior to invasive procedures has been associated with skin reactions such as chemical burns in neonates. Based on available case reports in the published literature, this risk appears to be higher in preterm infants, especially those born before 32 weeks of gestation and within the first 2 weeks of life. Remove any soaked materials, drapes or gowns before proceeding with the intervention. Do not use excessive quantities and do not allow the solution to pool in skin folds or under the patient or drip on sheets or other material in direct contact with the patient. Where occlusive dressings are to be applied to areas previously exposed to Chlorhexidine, care must be taken to ensure no excess product is present prior to application of the dressing. Seek urgent medical attention if Chlorhexidine Acetate with Cetrimide Antiseptic Solution is swallowed. If ingested, Cetrimide may cause nausea and vomiting. Swallowing this solution may cause oesophageal damage or necrosis. Demulcents may be given, but emesis and lavage should be avoided. Accidental intra-uterine or intravenous administration may cause haemolysis. It should not be used if you have a history of allergy to any of the ingredients of Chlorhexidine Acetate with Cetrimide Antiseptic Solution. Some patients become hypersensitive to Cetrimide after repeated applications. The use of chlorhexidine as a mouthwash has been associated with reversible discolouration of the tongue, teeth and silicate or composite dental restorations. Page 2 of 5

It should not be used if the expiry date printed on the label is overdue. Do not use unless the solution is clear, free of particles and the tamperproof seal is intact. Incompatibility Prolonged immersion of rubber appliances in these solutions should be avoided. Chlorhexidine is incompatible with soaps, other anionic materials and with potassium iodide. Use in Pregnancy Category A The Prescribing Medicines in Pregnancy booklet categorises chlorhexidine as a Category A medicine. Use in Lactation This product is safe for use in lactation. Paediatric Use This product is safe for use on children. INTERACTIONS WITH OTHER MEDICINES The action of chlorhexidine is reduced by an alkaline ph, the presence of organic matter, anionic detergents and tannins. ADVERSE EFFECTS Anaphylactic/anaphylactoid reactions to chlorhexidine have been reported. Manifestations of such reactions have included hypotension, bronchospasm, rash, erythema, tachycardia, and shock. Fatal anaphylactic reaction has been reported. Some patients may experience skin irritation or an allergic reaction/ hypersensitivity reactions on contact with this product. If this occurs, the use of this product should be stopped immediately. Skin sensitivity to chlorhexidine has occasionally been reported. Very occasionally the following reactions have been noted when chlorhexidine containing irrigating solutions have been used intravesically, intravaginally or topically on traumatised skin: hypotension, paraesthesia, dyspnoea, tachycardia cold sweat, generalized erythema, urticaria and loss of consciousness. Strong solutions may cause irritation of the conjunctiva and other sensitive tissues. Transient taste disturbances and a burning sensation of the tongue may occur on initial use. Oral desquamation and occasional parotid gland swelling have been reported with the mouthwash. If desquamation occurs, a 50% dilution of the mouthwash with water and less vigorous rinsing may allow continued use. Page 3 of 5

Chemical burns in neonates have been reported with similar chlorhexidine solutions (see PRECAUTIONS) DOSAGE AND ADMINISTRATION Dosage As required to disinfect wound area. See directions for use. Directions for use The area where Chlorhexidine Acetate with Cetrimide Antiseptic Solution is to be used should be rinsed thoroughly with water. Apply the minimum amount necessary to cover the wound area and wash gently. Leave the area to dry by air for 3 minutes. Use undiluted. Do not mix with detergents or other chemicals. Discard within 24 hours of opening. To open Hold Steripour bottle and twist lid to open, breaking the tamper proof seal. OVERDOSAGE If taken by mouth, cetrimide and other quaternary ammonium compounds cause nausea and vomiting. If ingested, advice concerning treatment should be sought immediately from a Doctor or contact the Poison Information Centre on 131126. PRESENTATION AND STORAGE CONDITIONS Chlorhexidine Acetate with Cetrimide Antiseptic Solutions are supplied in 3 strengths. Each strength has 3 sizes (see Table 1). Table 1 Strength Pack Size Product Code ARTG Number Chlorhexidine Acetate 0.015% Cetrimide 0.15% 100 ml AHF7971 19458 Chlorhexidine Acetate 0.015% Cetrimide 0.15% 500 ml AHF7970 19458 Chlorhexidine Acetate 0.015% Cetrimide 0.15% 1000 ml AHF7969 19458 Chlorhexidine Acetate 0.05% Cetrimide 0.5% 100 ml AHF7979 19460 Chlorhexidine Acetate 0.05% Cetrimide 0.5% 500 ml AHF7988 19460 Chlorhexidine Acetate 0.05% Cetrimide 0.5% 1000 ml AHF7987 19460 Chlorhexidine Acetate 0.10% Cetrimide 1.0% 100 ml AHF7973 19462 Chlorhexidine Acetate 0.10% Cetrimide 1.0% 500 ml AHF7972 19462 Chlorhexidine Acetate 0.10% Cetrimide 1.0% 1000 ml AHF7968 19462 Page 4 of 5

Storage Conditions Chlorhexidine Acetate with Cetrimide Antiseptic Solution should be stored below 30 C. Do not heat in excess of 80 C. Protect from light. NAME AND ADDRESS OF THE SPONSOR Baxter Healthcare Pty. Ltd., 1 Baxter Drive Old Toongabbie, NSW 2146. POISON SCHEDULE OF THE MEDICINE: Not scheduled. DATE OF FIRST INCLUSION ON THE AUSTRALIAN REGISTER OF THERAPEUTIC GOODS: 30 September 1991 DATE OF MOST RECENT AMENDMENT: 19 February 2015 Page 5 of 5